CHRISTINA PAYTON: Open Payments
NPI 1659059020 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,022 in 80 payments from 15 companies in 2025. Trend: 2023 $390 · 2024 $1,065 · 2025 $2,022
Food & beverage: $1,904Education: $118
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $436 |
| Otsuka America Pharmaceutical, Inc. | 13 | $286 |
| Alkermes, Inc. | 12 | $271 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $177 |
| Teva Pharmaceuticals USA, Inc. | 4 | $151 |
| Axsome Therapeutics, Inc. | 6 | $147 |
| E.R. Squibb & Sons, L.L.C. | 3 | $135 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $132 |
| Vanda Pharmaceuticals Inc. | 5 | $127 |
| ABBVIE INC. | 2 | $37 |
Products named: SPRAVATO, ARISTADA, REXULTI, CAPLYTA, Auvelity, COBENFY, INVEGA SUSTENNA, FANAPT.
Industry payments across IN — which companies pay providers there.
